EUVIMEDEUVIMED entdecken
Crossref

Discrimination in the clinical diagnosis between patients with schizophrenia and healthy controls using eye movement and cognitive functions

Kosuke Okazaki, Kenichiro Miura iD, Junya Matsumoto iD, Naomi Hasegawa, Michiko Fujimoto, Hidenaga Yamamori, Yuka Yasuda iD, Manabu Makinodan iD, Ryota Hashimoto iD

Psychiatry and Clinical Neurosciences · 2023

DOI: 10.1111/pcn.13553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatry and Clinical Neurosciences, 2023. Verfasst von Kosuke Okazaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Cognition Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, National Center of Neurology and Psychiatry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Eye movements and cognitive functions are significantly impaired in patients with schizophrenia. The authors aimed to develop promising clinical diagnostic markers that fit practical digital health applications in psychiatry using eye movement and cognitive function data from 1254 healthy individuals and 336 patients with schizophrenia.

Methods

Multivariate analyses using logistic regression were performed to confirm net performance of eye movements and cognitive functions scored using the Wechsler Adult Intelligence Scale, Third Edition, and Wechsler Memory Scale‐Revised. The authors then examined the discrimination performance of pairs containing an eye movement and a cognitive function measure to search the pairs that would be effective in practical application for the discrimination according to the diagnostic criterion between the groups.

Results

Multivariate analyses confirmed that eye movements and cognitive functions were effective modalities for discriminating between patients with schizophrenia and healthy controls. The discriminant analyses of the pairs demonstrated that seven eye movement measures and seven scores from cognitive function tests showed high discrimination performance when paired with one measure from the other modality. Moreover, seven pairs of digit‐symbol coding or symbol‐search and eye movement measures had high and robust discrimination performance.

Conclusion

Seven pairs of an eye movement and a cognitive function measure were effective, robust, and less time‐consuming in assisting with clinical diagnosis by categorizing healthy individuals or patients with schizophrenia. These findings may help develop an objective auxiliary diagnosis method working even on portable devices, which facilitates the consistency of diagnosis, earlier intervention, and shared decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaCognition DisordersAdultHumansEye MovementsCognitionIntelligence TestsNeuropsychological Tests

Stichwörter der Autor:innen

cognitive functiondiagnostic markereye movementreceiver operating characteristic analysisschizophrenia

Autor:innen und Institutionen

  • Department of Psychiatry, Nara Medical University School of Medicine, Nara, Japan.
  • Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Department of Psychiatry, Osaka University Graduate School of Medicine, Suita, Japan.
  • Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.
  • Medical Corporation Foster, Osaka, Japan.

ORCID-Profile: Kenichiro Miura, Junya Matsumoto, Yuka Yasuda, Manabu Makinodan, Ryota Hashimoto

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • National Center of Neurology and Psychiatry

Zitieren

APA

Okazaki, K., Miura, K., Matsumoto, J., Hasegawa, N., Fujimoto, M., Yamamori, H., Yasuda, Y., Makinodan, M., & Hashimoto, R. (2023). Discrimination in the clinical diagnosis between patients with schizophrenia and healthy controls using eye movement and cognitive functions. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13553

Vancouver

Okazaki K, Miura K, Matsumoto J, Hasegawa N, Fujimoto M, Yamamori H, et al. Discrimination in the clinical diagnosis between patients with schizophrenia and healthy controls using eye movement and cognitive functions. Psychiatry and Clinical Neurosciences. 2023. doi:10.1111/pcn.13553

BibTeX
@article{Okazaki2023,
  author = {Okazaki, Kosuke and Miura, Kenichiro and Matsumoto, Junya and Hasegawa, Naomi and Fujimoto, Michiko and Yamamori, Hidenaga and Yasuda, Yuka and Makinodan, Manabu and Hashimoto, Ryota},
  title = {Discrimination in the clinical diagnosis between patients with schizophrenia and healthy controls using eye movement and cognitive functions},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2023},
  doi = {10.1111/pcn.13553}
}
Kostenlos starten →